Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 6—June 2015
CME ACTIVITY - Research

Estimated Deaths and Illnesses Averted During Fungal Meningitis Outbreak Associated with Contaminated Steroid Injections, United States, 2012–2013

Rachel SmithComments to Author , Gordana Derado, Matthew Wise, Julie R. Harris, Tom M. Chiller, Martin I. Meltzer, and Benjamin Park
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 1

Methylprednisolone acetate (MPA) injections shipped, used, and recalled by lot*

Lot no. Volume MPA shipped, mL Volume MPA used, mL Volume MPA recalled, mL
05 11,773 11,773 0
06 10,847 10,715 132
08
 7,021
 4,003
 3,018
Total 29,641 26,491 3,150

*Volume of MPA shipped was derived from New England Compounding Center’s shipping records. Volume used and recalled was estimated by using the assumption that all shipped MPA was available for use at each clinic.

Main Article

Page created: October 06, 2015
Page updated: October 06, 2015
Page reviewed: October 06, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external